FDA Inspection 1165555 — BioLife Plasma Services LP

BioLife Plasma Services LP — FEI 3017670443

The FDA completed an inspection of BioLife Plasma Services LP on Mar 25, 2022 in Aurora, CO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 25, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Aurora, CO (United States)

Citations

IDCFRDescription
9821 CFR 606.100(c)Thorough investigations